[go: up one dir, main page]

GB2000029A - Anthraquinones for Cancer Therapy - Google Patents

Anthraquinones for Cancer Therapy

Info

Publication number
GB2000029A
GB2000029A GB7827474A GB7827474A GB2000029A GB 2000029 A GB2000029 A GB 2000029A GB 7827474 A GB7827474 A GB 7827474A GB 7827474 A GB7827474 A GB 7827474A GB 2000029 A GB2000029 A GB 2000029A
Authority
GB
United Kingdom
Prior art keywords
anthraquinones
cancer therapy
cancer
therapy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7827474A
Other versions
GB2000029B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Honeywell International Inc
Original Assignee
Allied Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ZA00774443A priority Critical patent/ZA774443B/en
Priority to SE7708452A priority patent/SE7708452L/en
Priority to JP9316877A priority patent/JPS5428827A/en
Priority to BE179924A priority patent/BE857494R/en
Priority to FR7724214A priority patent/FR2399244A2/en
Application filed by Allied Chemical Corp filed Critical Allied Chemical Corp
Priority to GB7827474A priority patent/GB2000029B/en
Priority to GB7923012A priority patent/GB2036554A/en
Publication of GB2000029A publication Critical patent/GB2000029A/en
Application granted granted Critical
Publication of GB2000029B publication Critical patent/GB2000029B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Anthraquinones of the formula: <IMAGE> wherein R is an alkylene group having 1 to 4 carbon atoms, if desired in the form of a pharmaceutical composition, are used for the therapy of cancer.
GB7827474A 1977-07-22 1978-06-21 Anthraquinones for cancer therapy Expired GB2000029B (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ZA00774443A ZA774443B (en) 1977-07-22 1977-07-22 Anthrquinone compounds as anti-cancer agents
SE7708452A SE7708452L (en) 1977-07-22 1977-07-22 COMPOSITION CONTAINING AN ANTHRAKINON COMPOUND
JP9316877A JPS5428827A (en) 1977-07-22 1977-08-02 Anthraquinone compound as cancer controlling agent
BE179924A BE857494R (en) 1977-07-22 1977-08-04 ANTHRAQUINONE COMPOUNDS USEFUL FOR DYES AND TEXTILES AND AS ACTIVE AGENTS AGAINST LEUKEMIA
FR7724214A FR2399244A2 (en) 1977-07-22 1977-08-05 COMPOSITIONS BASED ON ANTHRAQUINONIC COMPOUNDS USED AS ANTI-CANCER AGENTS
GB7827474A GB2000029B (en) 1977-07-22 1978-06-21 Anthraquinones for cancer therapy
GB7923012A GB2036554A (en) 1977-07-22 1978-06-21 Anthraquinones for use in therapy

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
ZA00774443A ZA774443B (en) 1977-07-22 1977-07-22 Anthrquinone compounds as anti-cancer agents
SE7708452A SE7708452L (en) 1977-07-22 1977-07-22 COMPOSITION CONTAINING AN ANTHRAKINON COMPOUND
JP9316877A JPS5428827A (en) 1977-07-22 1977-08-02 Anthraquinone compound as cancer controlling agent
BE179924A BE857494R (en) 1977-07-22 1977-08-04 ANTHRAQUINONE COMPOUNDS USEFUL FOR DYES AND TEXTILES AND AS ACTIVE AGENTS AGAINST LEUKEMIA
FR7724214A FR2399244A2 (en) 1977-07-22 1977-08-05 COMPOSITIONS BASED ON ANTHRAQUINONIC COMPOUNDS USED AS ANTI-CANCER AGENTS
GB7827474A GB2000029B (en) 1977-07-22 1978-06-21 Anthraquinones for cancer therapy
GB7923012A GB2036554A (en) 1977-07-22 1978-06-21 Anthraquinones for use in therapy

Publications (2)

Publication Number Publication Date
GB2000029A true GB2000029A (en) 1979-01-04
GB2000029B GB2000029B (en) 1982-01-06

Family

ID=27560757

Family Applications (2)

Application Number Title Priority Date Filing Date
GB7923012A Withdrawn GB2036554A (en) 1977-07-22 1978-06-21 Anthraquinones for use in therapy
GB7827474A Expired GB2000029B (en) 1977-07-22 1978-06-21 Anthraquinones for cancer therapy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB7923012A Withdrawn GB2036554A (en) 1977-07-22 1978-06-21 Anthraquinones for use in therapy

Country Status (6)

Country Link
JP (1) JPS5428827A (en)
BE (1) BE857494R (en)
FR (1) FR2399244A2 (en)
GB (2) GB2036554A (en)
SE (1) SE7708452L (en)
ZA (1) ZA774443B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154117A1 (en) * 1984-02-27 1985-09-11 American Cyanamid Company Use of 1,4 bis(substituted) anthrachinones for the manufacture of immunosuppresiva
EP0503537A1 (en) * 1991-03-08 1992-09-16 The University Of Vermont 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones
GB2254554A (en) * 1991-02-13 1992-10-14 Radopath Ltd Pharmaceutical quinone composition
WO1995013813A1 (en) * 1993-11-17 1995-05-26 Duke University Aminoanthraquinone derivatives to combat multidrug resistance

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8923075D0 (en) * 1989-10-13 1989-11-29 Patterson Laurence H Anti-cancer compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154117A1 (en) * 1984-02-27 1985-09-11 American Cyanamid Company Use of 1,4 bis(substituted) anthrachinones for the manufacture of immunosuppresiva
AU581878B2 (en) * 1984-02-27 1989-03-09 American Cyanamid Company Method of treating multiple sclerosis, rheumatoid arthritis or organ transplant rejection
GB2254554A (en) * 1991-02-13 1992-10-14 Radopath Ltd Pharmaceutical quinone composition
GB2254554B (en) * 1991-02-13 1995-09-20 Radopath Ltd Pharmaceutical quinone compositions
EP0503537A1 (en) * 1991-03-08 1992-09-16 The University Of Vermont 6,9 Bis(substituted-amino)benzo-[g]isoquinoline-5,10-diones
EP0575526A4 (en) * 1991-03-08 1994-03-30 The University Of Vermont
WO1995013813A1 (en) * 1993-11-17 1995-05-26 Duke University Aminoanthraquinone derivatives to combat multidrug resistance
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance

Also Published As

Publication number Publication date
GB2000029B (en) 1982-01-06
ZA774443B (en) 1978-06-28
FR2399244A2 (en) 1979-03-02
FR2399244B2 (en) 1982-04-23
GB2036554A (en) 1980-07-02
BE857494R (en) 1978-02-06
SE7708452L (en) 1979-01-23
JPS5428827A (en) 1979-03-03

Similar Documents

Publication Publication Date Title
SE7607597L (en) SPERMICID VAGINAL COMPOSITION INCLUDING 1,2-BENSISOTIAZOLE DERIVATIVES
IL58086A (en) 9-(hydroxyalkyl)-hypoxanthines
SE8200171L (en) 3-AMINOPROPOXIARYL DERIVATIVES, PREPARING THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE
ZA824438B (en) Novel 2-aryl-3,4-diazabicyclo-(4.n.o)alk-2-en-5-ones their preparation,and drugs containing them
ES8101530A1 (en) beta , gamma -Dihydropolyprenyl alcohol and hypotensive pharmaceutical composition containing same
GB2000029A (en) Anthraquinones for Cancer Therapy
GB2005253B (en) Process for the preparation of p-benzoquinone diketals
IL60323A0 (en) Pseudotrisaccharide compounds,their preparation and their medicinal use
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
JPS57185282A (en) Benzopyrane ether, manufacture and anti-allergic medicine containing same
JPS5610200A (en) Anthracycline glycoside* its manufacture and medicinal composition containing same for tumor treatment
ES466192A1 (en) Isoquinoline derivatives and pharmaceutical compositions containing them
ES8304548A1 (en) Phenethanol amine derivatives, their preparation and use in medicine.
ES434026A1 (en) Hydroxy and ether containing phenothiazine derivatives
PH24207A (en) 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles
AU527523B2 (en) Hexahydro-1,4-oxazepines
FR2446841A1 (en) PROCESS FOR THE PREPARATION OF 1A, 3B-DIHYDROXY-D5-STEROIDES
FR2414513A1 (en)
ES467886A1 (en) 3 beta -Hydroxy-18 beta -olean-9-en-30-oic acids
ES486580A1 (en) A PROCEDURE FOR PREPARING COMPOUNDS WITH BRONCHODILATING PROPERTIES
AU6306886A (en) Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine
ES526898A0 (en) PROCEDURE FOR THE PREPARATION OF NEW 7-ACILTIO-1, 2 -METILEN-3-OXO-17 -PREGN-4-EN-21,17-CARBOLACTONES
SE7903971L (en) ANTITUMORDEOXIANTRACYCLINES
IL60383A0 (en) Cyclophosphathiazene derivatives,their preparation and pharmaceutical compositions containing them
FR2430933A1 (en) PROPIOPHENONE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee